SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-008426
Filing Date
2020-01-16
Accepted
2020-01-16 06:32:33
Documents
3
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873828d8k.htm 8-K 21821
2 EX-4.1 d873828dex41.htm EX-4.1 78723
3 EX-10.1 d873828dex101.htm EX-10.1 53725
  Complete submission text file 0001193125-20-008426.txt   155562
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 20529415
SIC: 2834 Pharmaceutical Preparations